Author: Jing Liu; Sumeng Li; Jia Liu; Boyun Liang; Xiaobei Wang; Hua Wang; Wei Li; Qiaoxia Tong; Jianhua Yi; Lei Zhao; Lijuan Xiong; Chunxia Guo; Jin Tian; Jinzhuo Luo; Jinghong Yao; Ran Pang; Hui Shen; Cheng Peng; Ting Liu; Qian Zhang; Jun Wu; Ling Xu; Sihong Lu; Baoju Wang; Zhihong Weng; Chunrong Han; Huabing Zhu; Ruxia Zhou; Helong Zhou; Xiliu Chen; Pian Ye; Bin Zhu; Shengsong He; Yongwen He; Shenghua Jie; Ping Wei; Jianao Zhang; Yinping Lu; Weixian Wang; Li Zhang; Ling Li; Fengqin Zhou; Jun Wang; Ulf Dittmer; Mengji Lu; Yu Hu; Dongliang Yang; Xin Zheng
Title: Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients Document date: 2020_2_18
ID: 9xmeyrtu_14
Snippet: However, the differences in CD4 T cell counts between the two groups did not reach a statistical significance at any time point ( Figure 2C ). The T cell counts started to gradually increase in the severe group starting at 7 days after disease onset, and reached comparable levels to those in the mild patients on day 16 after disease onset ( Figure 2A -C). No significant differences in B cell and NK cell counts were observed between the two groups.....
Document: However, the differences in CD4 T cell counts between the two groups did not reach a statistical significance at any time point ( Figure 2C ). The T cell counts started to gradually increase in the severe group starting at 7 days after disease onset, and reached comparable levels to those in the mild patients on day 16 after disease onset ( Figure 2A -C). No significant differences in B cell and NK cell counts were observed between the two groups during the whole course of the disease ( Figure 2D and 2E).
Search related documents:
Co phrase search for related documents- cell count and group cell count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cell count and mild patient: 1, 2, 3, 4, 5, 6
- cell count and NK cell count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- cell count and severe group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cell count and significant difference: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cell count and statistical significance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- cell count and statistical significance reach: 1, 2
- cell count and time point: 1, 2, 3, 4, 5, 6, 7, 8
- comparable level and disease course: 1
- comparable level and mild patient: 1
- comparable level and severe group: 1, 2
- comparable level and significant difference: 1, 2, 3
- comparable level and time point: 1
- disease course and mild patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- disease course and severe group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- disease course and significant difference: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- disease course and statistical significance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- disease course and statistical significance reach: 1, 2, 3, 4
- disease course and time point: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
Co phrase search for related documents, hyperlinks ordered by date